The absence of p53 activation after MX25-1-mediated degradation of MDM2 is consistent with siRNA-mediated knockout of MDM2 in MYCN-amplified NB cells, which also fails to activate p53, as reported in our previous publication (21). The gene discussed is MYCN; the disease is neuroblastoma.